Skip to main content

Advertisement

Log in

Anti-Inflammatory Activity of Ghrelin in Human Carotid Artery Cells

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Receptors for eicosanoids such as prostaglandin E2, prostacyclin and thromboxane A2, as well as the ghrelin receptor polypeptide (GHS-R1b), can all regulate ghrelin (GHS-R1a) receptor activity, by the process of hetero-oligomerization, when heterologously expressed in human embryonic kidney (HEK 293) cells. To determine if such regulation might occur in inflammatory diseases of the vasculature, we incubated human coronary artery endothelial cells and human coronary artery smooth muscle cells with lipopolysaccharide and determined mRNA expression levels of these proteins using real-time PCR. Acute inflammation increased GHS-R1a mRNA in smooth muscle cells and increased cyclo-oxygenase-2 mRNA in endothelial cells; both these changes were attenuated by pretreatment of cells with ghrelin. Lipopolysaccharide did not affect expression of GHS-R1b or prostanoid receptor mRNA. Therefore, hetero-oligomerization of GHS-R1a with GHS-R1b or prostanoid receptors is unlikely to influence GHS-R1a activity in the vasculature; at least under conditions of acute vascular inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Holst, B., and T. W. Schwartz. 2004. Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation. Trends Pharmacol. Sci. 25:113–117.

    Article  CAS  PubMed  Google Scholar 

  2. Wiley, K. E., and A. P. Davenport. 2002. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br. J. Pharmacol. 136:1146–1152.

    Article  CAS  PubMed  Google Scholar 

  3. Waseem, T., M. Duxbury, H. Ito, S. W. Ashley, and M. K. Robinson. 2008. Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery. 143:334–342.

    Article  PubMed  Google Scholar 

  4. Katugampola, S. D., R. E. Kuc, J. J. Maguire, and A. P. Davenport. 2002. G-protein-coupled receptors in human atherosclerosis: comparison of vasoconstrictors (endothelin and thromboxane) with recently de-orphanized (urotensin-II, apelin and ghrelin) receptors. Clin. Sci. 103(Suppl. 48):171S–175S.

    CAS  PubMed  Google Scholar 

  5. Iantorno, M., H. Chen, J. Kim, M. Tesauro, D. Lauro, C. Cardillo, and M. J. Quon. 2007. Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells. Am. J. Physiol. Endocrinol. Metab. 292:E756–E764.

    Article  CAS  PubMed  Google Scholar 

  6. Xu, X., B. Sook Jhun, C. Hoon Ha, and Z. G. Jin. 2008. Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. Endocrinology. 149:4183–4192.

    Article  CAS  PubMed  Google Scholar 

  7. Leung, P. K., K. B. S. Chow, P. N. Lau, K. M. Chu, C. B. Chan, C. H. K. Cheng, and H. Wise. 2007. The truncated ghrelin receptor polypeptide (GHS-R1b) acts as a dominant-negative mutant of the ghrelin receptor. Cell Signal. 19:1011–1022.

    Article  CAS  PubMed  Google Scholar 

  8. Chow, K. B. S., P. K. Leung, C. H. K. Cheng, W. T. Cheung, and H. Wise. 2008. The constitutive activity of ghrelin receptors is decreased by co-expression with vasoactive prostanoid receptors when over-expressed in human embryonic kidney 293 cells. Int. J. Biochem. Cell Biol. 40:2627–2637.

    Article  CAS  PubMed  Google Scholar 

  9. Cipollone, F., and M. L. Fazia. 2006. COX-2 and atherosclerosis. J. Cardiovasc. Pharmacol. 47:S26–S36.

    Article  CAS  PubMed  Google Scholar 

  10. Norel, X. 2007. Prostanoid receptors in the human vascular wall. Scientific World Journal. 7:1359–1374.

    CAS  PubMed  Google Scholar 

  11. Gómez-Hernández, A., J. L. Martín-Ventura, E. Sánchez-Galán, C. Vidal, M. Ortego, L. M. Blanco-Colio, L. Ortega, J. Tuñón, and J. Egido. 2006. Overexpression of COX-2, prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: regulation by nuclear factor-κB. Atherosclerosis. 187:139–149.

    Article  PubMed  CAS  Google Scholar 

  12. Murata, T., F. Ushikubi, T. Matsuoka, M. Hirata, A. Yamasaki, Y. Sugimoto, A. Ichikawa, Y. Aze, T. Tanaka, N. Yoshida, A. Ueno, S. Oh-Ishi, and S. Narumiya. 1997. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature. 388:678–682.

    Article  CAS  PubMed  Google Scholar 

  13. Kobayashi, T., Y. Tahara, M. Matsumoto, M. Iguchi, H. Sano, T. Murayama, H. Arai, H. Oida, T. Yurugi-Kobayashi, J. K. Yamashita, H. Katagiri, M. Majima, M. Yokode, T. Kita, and S. Narumiya. 2004. Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J. Clin. Invest. 114:784–794.

    CAS  PubMed  Google Scholar 

  14. Hung, G. H. Y., R. L. Jones, F. F. Y. Lam, K. M. Chan, H. Hidaka, M. Suzuki, and Y. Sasaki. 2006. Investigation of the pronounced synergism between prostaglandin E2 and other constrictor agents on rat femoral artery. Prostaglandins Leukot. Essent. Fatty Acids. 74:401–415.

    Article  CAS  PubMed  Google Scholar 

  15. Fabre, J.-E., M. Nguyen, K. Athirakul, K. Coggins, J. D. McNeish, S. Austin, L. K. Parise, G. A. Fitzgerald, T. M. Coffman, and B. H. Koller. 2001. Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation. J. Clin. Invest. 107:603–610.

    Article  CAS  PubMed  Google Scholar 

  16. Magder, S., J. Neculcea, V. Neculcea, and R. Sladek. 2006. Lipopolysaccharide and TNF-α produce very similar changes in gene expression in human endothelial cells. J. Vasc. Res. 43:447–461.

    Article  CAS  PubMed  Google Scholar 

  17. Wu, S.-Q., and W. C. Aird. 2005. Thrombin, TNF-α, and LPS exert overlapping but nonidentical effects on gene expression in endothelial cells and vascular smooth muscle cells. Am. J. Physiol. 289:H873–H885.

    CAS  Google Scholar 

  18. Rozen, S., H. J. Skaletsky 2000. Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology, Krawetz S, Misener S, eds. Totowa: Humana Press; 365–386.

  19. Viani, I., A. Vottero, F. Tassi, G. Cremonini, C. Sartori, S. Bernasconi, B. Ferrari, and L. Ghizzoni. 2008. Ghrelin Inhibits steroid biosynthesis by cultured granulosa-lutein cells. J. Clin. Endocrinol. Metab. 93:1476–1481.

    Article  CAS  PubMed  Google Scholar 

  20. Kotelevets, L., N. Foudi, L. Louedec, A. Couvelard, E. Chastre, and X. Norel. 2007. A new mRNA splice variant coding for the human EP3-I receptor isoform. Prostaglandins Leukot. Essent. Fatty Acids. 77:195–201.

    Article  CAS  PubMed  Google Scholar 

  21. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 25:402–408.

    Article  CAS  PubMed  Google Scholar 

  22. Whelan, J. A., N. B. Russell, and M. A. Whelan. 2003. A method for the absolute quantification of cDNA using real-time PCR. J. Immunol. Methods. 278:261–269.

    Article  CAS  PubMed  Google Scholar 

  23. De Vriese, C., F. Gregoire, P. De Neef, P. Robberecht, and C. Delporte. 2005. Ghrelin is produced by the human erythroleukemic HEL cell line and involved in an autocrine pathway leading to cell proliferation. Endocrinology. 146:1514–1522.

    Article  PubMed  CAS  Google Scholar 

  24. Wu, R., M. Zhou, X. Cui, H. H. Simms, and P. Wang. 2004. Upregulation of cardiovascular ghrelin receptor occurs in the hyperdynamic phase of sepsis. Am. J. Physiol. 287:H1296–H1302.

    Article  CAS  Google Scholar 

  25. Li, A., G. Cheng, G. H. Zhu, and A. S. Tarnawski. 2007. Ghrelin stimulates angiogenesis in human microvascular endothelial cells: implications beyond GH release. Biochem. Biophys. Res. Commun. 353:238–243.

    Article  CAS  PubMed  Google Scholar 

  26. Gnanapavan, S., B. Kola, S. A. Bustin, D. G. Morris, P. McGee, P. Fairclough, S. Bhattacharya, R. Carpenter, A. B. Grossman, and M. Korbonits. 2002. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab. 87:2988–2991.

    Article  CAS  PubMed  Google Scholar 

  27. Barzon, L., M. Pacenti, G. Masi, A. L. Stefani, K. Fincati, and G. Palù. 2005. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors. Oncology. 68:414–421.

    Article  CAS  PubMed  Google Scholar 

  28. Luque, R. M., R. D. Kineman, S. Park, X. D. Peng, F. Gracia-Navarro, J. P. Castano, and M. M. Malagon. 2004. Homologous and heterologous regulation of pituitary receptors for ghrelin and growth hormone-releasing hormone. Endocrinology. 145:3182–3189.

    Article  CAS  PubMed  Google Scholar 

  29. Yeung, C. M., C. B. Chan, and C. H. K. Cheng. 2004. Isolation and characterization of the 5′-flanking region of the growth hormone secretagogue receptor gene from black seabream Acanthopagrus schlegeli. Mol. Cell. Endocrinol. 223:5–15.

    Article  CAS  PubMed  Google Scholar 

  30. Barreiro, M. L., L. Pinilla, E. Aguilar, and M. Tena-Sempere. 2002. Expression and homologous regulation of GH secretagogue receptor mRNA in rat adrenal gland. Eur. J. Endocrinol. 147:677–688.

    Article  CAS  PubMed  Google Scholar 

  31. Holst, B., N. D. Holliday, A. Bach, C. E. Elling, H. M. Cox, and T. W. Schwartz. 2004. Common structural basis for constitutive activity of the ghrelin receptor family. J. Biol. Chem. 279:53806–53817.

    Article  CAS  PubMed  Google Scholar 

  32. Mousseaux, D., L. Le Gallic, J. Ryan, C. Oiry, D. Gagne, J. A. Fehrentz, J. C. Galleyrand, and J. Martinez. 2006. Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKCε pathway. Br. J. Pharmacol. 148:350–365.

    Article  CAS  PubMed  Google Scholar 

  33. Rossi, F., A. Castelli, M. J. Bianco, C. Bertone, M. Brama, and V. Santiemma. 2008. Ghrelin induces proliferation in human aortic endothelial cells via ERK1/2 and PI3K/Akt activation. Peptides. 29:2046–2051.

    Article  CAS  PubMed  Google Scholar 

  34. Rossi, F., A. Castelli, M. J. Bianco, C. Bertone, M. Brama, and V. Santiemma. 2009. Ghrelin inhibits contraction and proliferation of human aortic smooth muscle cells by cAMP/PKA pathway activation. Atherosclerosis. 203:97–104.

    Article  CAS  PubMed  Google Scholar 

  35. Cao, J. M., H. Ong, and C. Chen. 2006. Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system. Trends Endocrinol. Metab. 17:13–18.

    Article  CAS  PubMed  Google Scholar 

  36. Tan, X., S. Essengue, J. Talreja, J. Reese, D. J. Stechschulte, and K. N. Dileepan. 2007. Histamine directly and synergistically with lipopolysaccharide stimulates cyclooxygenase-2 expression and prostaglandin I2 and E2 production in human coronary artery endothelial cells. J. Immunol. 179:7899–7906.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region (GRF475807) and The Chinese University of Hong Kong (CUHK2041298).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Helen Wise.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chow, K.B., Cheng, C.H. & Wise, H. Anti-Inflammatory Activity of Ghrelin in Human Carotid Artery Cells. Inflammation 32, 402–409 (2009). https://doi.org/10.1007/s10753-009-9149-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-009-9149-8

KEY WORDS

Navigation